Fibroblast growth factor 23 (FGF23) modulates the metabolism of minerals and vitamin D. In chronic kidney disease (CKD), this process is disturbed owing to decreased parathyroid expression of FGF23's receptor complex Klotho-FGF receptor 1. In this issue, Krajisnik and colleagues demonstrate that similar alterations occur in parathyroid glands from kidney transplant recipients in association with a decline in allograft function. Is it possible that these data can be extrapolated to general early-stage CKD patients
BACKGROUND: Fibroblast growth factor 23 (FGF23), a bone-derived phosphaturic hormone, is elevated in...
FGF23 is a bone-derived hormone that plays an important role in the regulation of phosphate and 1,25...
Dysregulated phosphate metabolism is a common consequence of chronic kidney disease, and is characte...
Current studies suggest that short-term exposure of parathyroid glands to fibroblast growth factor 2...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate...
Although fibroblast growth factor 23 (FGF23) acting through its receptor Klotho-FGFR1c decreases par...
Over the past few years there have been considerable advances in our understanding of the physiologi...
Compared to normal tissue, hyperplastic parathyroid glands of patients with chronic kidney disease o...
Phosphatonin fibroblast growth factor-23 (FGF-23) is involved in phosphate (P) excretion and vitamin...
In CKD patients various disturbances in vitamin D metabolism in addition to their classical effects ...
Fibroblast growth factor 23 (FGF23) modulates the metabolism of minerals and vitamin D. In chronic k...
Disturbances in mineral metabolism contribute to vascular calcification and mortality risk in chroni...
End-stage renal disease is a major health problem with many complications. Previous studies emphasiz...
FGF23 is a bone-derived hormone that plays an important role in the regulation of phosphate and 1,25...
BACKGROUND: Fibroblast growth factor 23 (FGF23), a bone-derived phosphaturic hormone, is elevated in...
FGF23 is a bone-derived hormone that plays an important role in the regulation of phosphate and 1,25...
Dysregulated phosphate metabolism is a common consequence of chronic kidney disease, and is characte...
Current studies suggest that short-term exposure of parathyroid glands to fibroblast growth factor 2...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate...
Although fibroblast growth factor 23 (FGF23) acting through its receptor Klotho-FGFR1c decreases par...
Over the past few years there have been considerable advances in our understanding of the physiologi...
Compared to normal tissue, hyperplastic parathyroid glands of patients with chronic kidney disease o...
Phosphatonin fibroblast growth factor-23 (FGF-23) is involved in phosphate (P) excretion and vitamin...
In CKD patients various disturbances in vitamin D metabolism in addition to their classical effects ...
Fibroblast growth factor 23 (FGF23) modulates the metabolism of minerals and vitamin D. In chronic k...
Disturbances in mineral metabolism contribute to vascular calcification and mortality risk in chroni...
End-stage renal disease is a major health problem with many complications. Previous studies emphasiz...
FGF23 is a bone-derived hormone that plays an important role in the regulation of phosphate and 1,25...
BACKGROUND: Fibroblast growth factor 23 (FGF23), a bone-derived phosphaturic hormone, is elevated in...
FGF23 is a bone-derived hormone that plays an important role in the regulation of phosphate and 1,25...
Dysregulated phosphate metabolism is a common consequence of chronic kidney disease, and is characte...